
BioInnovation Institute
AI Verified
Denmark
Venture Capital
https://bioinnovationinstitute.com
2200 Copenhagen, Denmark
2018
Criteria | Requirements | Match |
---|---|---|
Regions | Northern Europe |
00
|
Countries |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Sector |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Impact Area |
00 00 00
|
|
Stage | Seed, Bridge, Series A, Pre-Seed |
00
|
Ticket size |
00 00 00
-
00 00 00
USD
|
00
|
Monetization model |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Product readiness |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Client types |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
00
|
Min. revenue |
00 00 00
USD
|
00
|
Other |
00 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 0000 00 00
|
- |
Company description
BioInnovation Institute stands as a premier incubator for transformative ideas in the fields of planetary and human health, offering researchers and entrepreneurs the opportunity to translate laboratory discoveries into commercial ventures. As a Novo Nordisk Foundation Initiative, BII operates with the core mission of advancing human welfare and societal well-being through scientific innovation. The institute has established itself as a cornerstone in the Nordic life science ecosystem, providing comprehensive support for ventures at every developmental stage—from early conceptual phases to fully articulated business models ready for market entry.
The institute's physical infrastructure encompasses an impressive 3,500 square meters of state-of-the-art laboratory and office facilities, creating an environment where scientific excellence meets entrepreneurial ambition. Within this vibrant life science community, participants gain access to specialized equipment and technical resources that might otherwise be prohibitively expensive for early-stage ventures. This shared infrastructure model has proven particularly valuable for spin-outs from academic institutions and first-time entrepreneurs who benefit from reduced capital expenditure requirements during their critical formative stages.
BII's approach to nurturing life science startups extends beyond physical resources to include comprehensive business acceleration programs tailored to different maturity levels. These structured pathways provide entrepreneurs with commercial guidance, strategic planning support, and regulatory navigation assistance—critical components for successfully transitioning scientific discoveries into viable commercial entities. The institute's funding opportunities represent another significant advantage, offering capital infusions at various stages to address the notorious "valley of death" that claims many promising life science ventures before they can achieve market validation.
Perhaps most valuable is BII's extensive network of industry connections and high-level mentoring relationships that provide founders with access to seasoned executives, successful entrepreneurs, and subject matter experts. This mentorship ecosystem helps participants avoid common pitfalls while accelerating their learning curves through experiential knowledge transfer. The institute's track record includes supporting numerous ventures that have secured significant follow-on funding, established valuable partnerships with pharmaceutical companies, and advanced innovative therapies toward clinical applications—demonstrating BII's effectiveness in bridging the gap between academic research and commercial success in the life sciences sector.
Highlights
Ready to raise better?
Create your Free Account!
Frequently asked questions
BioInnovation Institute maintains its global headquarters in Denmark, serving as the strategic center for its operations. The company's primary corporate offices are located at 2200 Copenhagen, Denmark.
BioInnovation Institute focuses its investment activities on companies operating in the following stages: Seed, Bridge, Series A, Pre-Seed. BioInnovation Institute provides strategic capital and expertise to support promising businesses at these critical phases of development.
BioInnovation Institute maintains a strategic global investment presence, actively seeking opportunities across the following key regions: Northern Europe.
BioInnovation Institute was established in 2018, marking the beginning of its journey as an investment firm.
BioInnovation Institute is the following type of investment firm: Venture Capital. The organization provides capital and strategic support to entrepreneurs and growing companies.